Advances in Transepithelial Photorefractive Keratectomy versus Laser-Assisted In Situ Keratomileusis

被引:2
作者
Curca, Paul Filip [1 ,2 ]
Tataru, Catalina Ioana [1 ,2 ,3 ]
Sima, George [1 ,3 ]
Burcea, Marian [1 ,2 ]
Tataru, Calin Petru [1 ,2 ,3 ]
机构
[1] Carol Davila Univ Med & Pharm, Clin Dept Ophthalmol, Bucharest 020021, Romania
[2] Clin Hosp Ophthalmol Emergencies, Dept Ophthalmol, Bucharest 010464, Romania
[3] Alcor Clin, Bucharest 030829, Romania
关键词
Trans-PRK; LASIK; versus; transepithelial photorefractive keratomileusis; LASIK;
D O I
10.3390/diagnostics14050481
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
(1) Background: Laser-assisted refractive surgery is a safe and effective surgical correction of refractive error. For most patients, both the newer Trans-PRK and the established LASIK technique can produce the required surgical correction, sparking the question of which technique should be opted for. (2) Methods: The study prospectively evaluated 121 patients (230 eyes) for at least one month postoperatively; 66 patients (126 eyes) and 45 patients (85 eyes) returned for 6 months and 1 year follow-up. (3) Results: No statistical difference was recorded at 1 week or 1 month post-operation. At 6 months, a difference was found for spherical diopters (Trans-PRK -0.0476 +/- 0.7012 versus FS-LASIK +0.425 +/- 0.874, p = 0.004) and spherical equivalent (Trans-PRK -0.1994 +/- 0.0294 versus FS-LASIK +0.225 +/- 0.646, p = 0.025) but not for CYL D (Trans-PRK -0.3036 +/- 0.5251 versus FS-LASIK -0.4 +/- 0.820, p = 0.499). Uncorrected visual acuity was better for Trans-PRK 6 months post-operation (UCVA logMAR 0.02523 versus 0.0768 logMAR; p = 0.015 logMAR). At 1-year, Trans-PRK was favored for spherical diopters (Trans-PRK -0.0294 +/- 0.6493 versus FS-LASIK +0.646 +/- 0.909, p < 0.001) and spherical equivalent (Trans-PRK -0.218 +/- 0.784 versus FS-LASIK 0.372 +/- 1.08, p = 0.007). Overall speed in visual recovery, variance of results and surgically induced astigmatism were in favor of Trans-PRK. (4) Conclusions: The study reported improvements for Trans-PRK patients, with both techniques found to be safe and effective.
引用
收藏
页数:19
相关论文
共 19 条
[1]   Comparison of clinical outcomes of LASIK, Trans-PRK, and SMILE for correction of myopia [J].
Chang, Jin-Yu ;
Lin, Pei-Yu ;
Hsu, Chih-Chien ;
Liu, Catherine Jui-Ling .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (02) :145-151
[2]   Transepithelial photorefractive keratectomy. Results and clinical experiences [J].
de Ortueta, D. ;
von Rueden, D. .
OPHTHALMOLOGE, 2019, 116 (06) :534-541
[3]   High-speed recording of thermal load during laser trans-epithelial corneal refractive surgery using a 750 Hz ablation system [J].
De Ortueta, Diego ;
Arba-Mosquera, Samuel ;
Magnago, Thomas .
JOURNAL OF OPTOMETRY, 2019, 12 (02) :84-91
[4]   Early clinical outcomes and comparison between trans-PRK and PRK, regarding refractive outcome, wound healing, pain intensity and visual recovery time in a real-world setup [J].
Gaeckle, Harald C. .
BMC OPHTHALMOLOGY, 2021, 21 (01)
[5]   AstigMATIC: an automatic tool for standard astigmatism vector analysis [J].
Gauvin, Mathieu ;
Wallerstein, Avi .
BMC OPHTHALMOLOGY, 2018, 18
[6]   Femtosecond laser assisted in situ keratomileusis (FS-LASIK) yields better results than transepithelial photorefractive keratectomy (Trans-PRK) for correction of low to moderate grade myopia [J].
Gershoni, Assaf ;
Reitblat, Olga ;
Mimouni, Michael ;
Livny, Eitan ;
Nahum, Yoav ;
Bahar, Irit .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (06) :2914-2922
[7]   Predictive factors for efficacy and safety in refractive surgery for myopia [J].
Gomel, Nir ;
Negari, Shay ;
Frucht-Pery, Joseph ;
Wajnsztajn, Denise ;
Strassman, Eyal ;
Solomon, Abraham .
PLOS ONE, 2018, 13 (12)
[8]  
Guell JL, 1996, J REFRACT SURG, V12, P222
[9]   Comparison of visual quality after Femto-LASIK and TransPRK in patients with low and moderate myopia [J].
Jiang, Jingjing ;
Jhanji, Vishal ;
Sun, Lixia ;
Li, Jinyu ;
Zhang, Riping .
INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (06) :1419-1428
[10]  
Kang Min Ji, 2020, Korean J Ophthalmol, V34, P210, DOI 10.3341/kjo.2019.0087